Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Long-Term Deferred Tax (2018 - 2024)

OptimizeRx (OPRX) has disclosed Long-Term Deferred Tax for 7 consecutive years, with $4.5 million as the latest value for Q4 2024.

  • Quarterly Long-Term Deferred Tax rose 3.55% to $4.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2024, up 3.55% year-over-year, with the annual reading at $4.5 million for FY2024, 3.55% up from the prior year.
  • Long-Term Deferred Tax hit $4.5 million in Q4 2024 for OptimizeRx, up from $4.3 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $10.5 million in Q4 2022 to a low of $4.3 million in Q4 2023.
  • Historically, Long-Term Deferred Tax has averaged $5.8 million across 5 years, with a median of $4.5 million in 2020.
  • Biggest five-year swings in Long-Term Deferred Tax: soared 99.35% in 2022 and later tumbled 58.66% in 2023.
  • Year by year, Long-Term Deferred Tax stood at $4.5 million in 2020, then rose by 15.72% to $5.3 million in 2021, then skyrocketed by 99.35% to $10.5 million in 2022, then crashed by 58.66% to $4.3 million in 2023, then increased by 3.55% to $4.5 million in 2024.
  • Business Quant data shows Long-Term Deferred Tax for OPRX at $4.5 million in Q4 2024, $4.3 million in Q4 2023, and $10.5 million in Q4 2022.